Tom Decroo

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 40

Top Venues

PloS one

The European respiratory journal

International health

Journal of clinical medicine

Institute of Tropical Medicine Antwerp

Institute of Tropical Medicine Antwerp (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Tropical Medicine Antwerp Jun 01 2016

Belgium

Post Doctoral Researcher :: Clinical Sciences Department

Médecins Sans Frontières Brussels Jan 01 2014 - May 31 2016

Belgium

Operational Research programme officer :: Medical Department

Institute of Tropical Medicine Antwerp Jul 01 2013 - Dec 31 2013

Belgium

Emerging Voices coordinator :: Public Health Department

Médecins Sans Frontières Brussels Mar 15 2003 - Jun 30 2013

Mozambique

Medical field coordinator :: Tete project

Education History

Institute of Tropical Medicine Antwerp Sep 01 2014 - Jul 01 2017

Belgium

PHD

Institute of Tropical Medicine Antwerp Sep 01 2012 - Jul 05 2013

Belgium

MSC

Publications

Hiwot Melak Tesfahun, Layth Al-Salihi, Nadia Abdulkareem Al-Ani, Ahmed Asmer Mankhi, Ammar Mohammed, Chenery Ann E Lim, Riadh Abdulameer Al-Hilfi, Christelle G Jouego, Tom Decroo, Krystel Moussally, Gabriella Ferlazzo, Petros Isaakidis
Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq. PloS one 19 (1) (2024)
Anita Mesic, Ine Ilona Decuyper, Sadiqqullah Ishaq, Taiba Azizi, Fazal Hadi Ziamal, Shirbaz Amiri, Kees Keus, Moe Thandar Pyae, Khan Mohammed Mangal, Hashim Khan Amirzada, Assadullah Rasooli, Mohammad Reza Aloudal, Mohammad Zaher Daldar, Tom Decroo
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, Afghanistan. The European respiratory journal 63 (5) (2024)
Anita Mesic, Ine Ilona Decuyper, Sadiqqullah Ishaq, Taiba Azizi, Fazal Hadi Ziamal, Shirbaz Amiri, Kees Keus, Moe Thandar Pyae, Khan Mohammed Mangal, Hashim Khan Amirzada, Assadullah Rasooli, Mohammad Reza Aloudal, Mohammad Zaher Daldar, Tom Decroo
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, Afghanistan. The European respiratory journal 63 (5) (2024)
Hiwot Melak Tesfahun, Layth Al-Salihi, Nadia Abdulkareem Al-Ani, Ahmed Asmer Mankhi, Ammar Mohammed, Chenery Ann E Lim, Riadh Abdulameer Al-Hilfi, Christelle G Jouego, Tom Decroo, Krystel Moussally, Gabriella Ferlazzo, Petros Isaakidis
Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq. PloS one 19 (1) (2024)
Anita Mesic, Ine Ilona Decuyper, Sadiqqullah Ishaq, Taiba Azizi, Fazal Hadi Ziamal, Shirbaz Amiri, Kees Keus, Moe Thandar Pyae, Khan Mohammed Mangal, Hashim Khan Amirzada, Assadullah Rasooli, Mohammad Reza Aloudal, Mohammad Zaher Daldar, Tom Decroo
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based non-randomized clinical trial, Kandahar Afghanistan. The European respiratory journal (2024)
Anita Mesic, Ine Ilona Decuyper, Sadiqqullah Ishaq, Taiba Azizi, Fazal Hadi Ziamal, Shirbaz Amiri, Kees Keus, Moe Thandar Pyae, Khan Mohammed Mangal, Hashim Khan Amirzada, Assadullah Rasooli, Mohammad Reza Aloudal, Mohammad Zaher Daldar, Tom Decroo
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, Afghanistan. The European respiratory journal 63 (5) (2024)
Joelma Baduro, K Carter Mccabe, Nílzio Cavele, Américo José, Anchelda Mulimela, Mehol Jamnadas, Cremildo Manhiça, Celso Monjane, Sheila Nhachungue, Tom Decroo, Ivalda Macicame
Understanding male circumcision: insights from a peri-urban community in Maputo City, Mozambique. International health (2024)
Tinne Gils, Thandanani Madonsela, Mashaete Kamele, Irene Ayakaka, Alastair Van Heerden, Erika Vlieghe, Moniek Bresser, Tom Decroo, Lutgarde Lynen, Klaus Reither, Shannon Bosman
Low tuberculosis treatment initiation after positive tuberculosis lipoarabinomannan results. ERJ open research 10 (4) (2024)
Ni Ni Tun, Frank Smithuis, Nyan Lynn Tun, Myo Min Min Hteik, Myat Ko Ko, Lutgarde Lynen, Tom Decroo, Eric Florence, Tinne Gils
Uptake and challenges with daily oral pre-exposure prophylaxis among men who have sex with men and transgender women, suburban Yangon, Myanmar. International health (2024)
Anita Mesic, Ine Ilona Decuyper, Sadiqqullah Ishaq, Taiba Azizi, Fazal Hadi Ziamal, Shirbaz Amiri, Kees Keus, Moe Thandar Pyae, Khan Mohammed Mangal, Hashim Khan Amirzada, Assadullah Rasooli, Mohammad Reza Aloudal, Mohammad Zaher Daldar, Tom Decroo
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, Afghanistan. The European respiratory journal 63 (5) (2024)
Ni Ni Tun, Frank Smithuis, Nyan Lynn Tun, Myo Min Min Hteik, Myat Ko Ko, Lutgarde Lynen, Tom Decroo, Eric Florence, Tinne Gils
Uptake and challenges with daily oral pre-exposure prophylaxis among men who have sex with men and transgender women, suburban Yangon, Myanmar. International health (2024)
Hiwot Melak Tesfahun, Layth Al-Salihi, Nadia Abdulkareem Al-Ani, Ahmed Asmer Mankhi, Ammar Mohammed, Chenery Ann E Lim, Riadh Abdulameer Al-Hilfi, Christelle G Jouego, Tom Decroo, Krystel Moussally, Gabriella Ferlazzo, Petros Isaakidis
Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq. PloS one 19 (1) (2024)
Tinne Gils, Thandanani Madonsela, Mashaete Kamele, Irene Ayakaka, Alastair Van Heerden, Erika Vlieghe, Moniek Bresser, Tom Decroo, Lutgarde Lynen, Klaus Reither, Shannon Bosman
Low tuberculosis treatment initiation after positive tuberculosis lipoarabinomannan results. ERJ open research 10 (4) (2024)
Tinne Gils, Mashaete Kamele, Thandanani Madonsela, Shannon Bosman, Thulani Ngubane, Philip Joseph, Klaus Reither, Moniek Bresser, Erika Vlieghe, Tom Decroo, Irene Ayakaka, Lutgarde Lynen, Alastair Van Heerden
Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation. PloS one 18 (12) (2023)
Tinne Gils, Mashaete Kamele, Thandanani Madonsela, Shannon Bosman, Thulani Ngubane, Philip Joseph, Klaus Reither, Moniek Bresser, Erika Vlieghe, Tom Decroo, Irene Ayakaka, Lutgarde Lynen, Alastair Van Heerden
Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation. PloS one 18 (12) (2023)
Tinne Gils, Mashaete Kamele, Thandanani Madonsela, Shannon Bosman, Thulani Ngubane, Philip Joseph, Klaus Reither, Moniek Bresser, Erika Vlieghe, Tom Decroo, Irene Ayakaka, Lutgarde Lynen, Alastair Van Heerden
Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation. PloS one 18 (12) (2023)
Anita Mesic, Tom Decroo, Eric Florence, Koert Ritmeijer, Josefien van Olmen, Lutgarde Lynen
Systematic review on cumulative HIV viraemia among people living with HIV receiving antiretroviral treatment and its association with mortality and morbidity. International health (2023)
Tinne Gils, Mashaete Kamele, Thandanani Madonsela, Shannon Bosman, Thulani Ngubane, Philip Joseph, Klaus Reither, Moniek Bresser, Erika Vlieghe, Tom Decroo, Irene Ayakaka, Lutgarde Lynen, Alastair Van Heerden
Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation. PloS one 18 (12) (2023)
Anita Mesic, Tobias Homan, Annick Lenglet, Phone Thit, Htay Thet Mar, Saw Myat Sabai, Moe Pyae Thandar, Thin Thin Thwe, Aung Aung Kyaw, Tom Decroo, Alexander Spina, Cono Ariti, Koert Ritmeijer, Josefien Van Olmen, Htun Nyunt Oo, Lutgarde Lynen
Advanced HIV disease and associated attrition after re-engagement in HIV care in Myanmar from 2003 to 2019: a retrospective cohort study. International health (2022)
Chinmay Laxmeshwar, Mrinalini Das, Taanya Mathur, Tarun Israni, Santosh Jha, Aparna Iyer, Mabel Morales, Tom Decroo, Tinne Gils, Gabriella Ferlazzo, Kleio Iakovidi, Mariana Garcia, Petros Isaakidis
Psychiatric comorbidities among patients with complex drug-resistant tuberculosis in Mumbai, India. PloS one 17 (2) (2022)
Aboubacar Sidiki Magassouba, Souleymane Mahamadou Bassirou, Almamy Amara Touré, Boubacar Djelo Diallo, Soumana Alphazazi, Diao Cissé, Mohamed Sitan Keita, Elhadj Saidou Seyabatou, Adama Marie Bangoura, Hugues Asken Traoré, Tom Decroo, Jonathon R Campbell, Vanessa Veronese, Corinne Simone Collette Merle
Evaluating the Effectiveness of a Novel Systematic Screening Approach for Tuberculosis among Individuals Suspected or Recovered from COVID-19: Experiences from Niger and Guinea. Tropical medicine and infectious disease 7 (9) (2022)
Armand Van Deun, Valentin Bola, Rossin Lebeke, Michel Kaswa, Mohamed Anwar Hossain, Mourad Gumusboga, Gabriela Torrea, Bouke Catherine de Jong, Leen Rigouts, Tom Decroo
Acquired rifampicin resistance during first TB treatment: magnitude, relative importance, risk factors and keys to control in low-income settings. JAC-antimicrobial resistance 4 (2) (2022)
Olujuwon Ibiloye, Tom Decroo, Caroline Masquillier, Plang Jwanle, Prosper Okonkwo, Josefien van Olmen, Lutgarde Lynen, Sara Van Belle
Outcomes of a community-based antiretroviral therapy programme for key populations living with HIV in Benue State, Nigeria: protocol for a realist evaluation. BMJ open 12 (11) (2022)
Yves Habimana-Mucyo, Augustin Dushime, Patrick Migambi, Innocent Habiyambere, Jean Claude Semuto Ngabonziza, Tom Decroo
Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study. International health (2022)
Anita Mesic, Tom Decroo, Htay Thet Mar, Bart K M Jacobs, Moe Pyae Thandar, Thin Thin Thwe, Aung Aung Kyaw, Mitchell Sangma, David Beversluis, Elkin Bermudez-Aza, Alexander Spina, Darli Po Po Aung, Erwan Piriou, Koert Ritmeijer, Josefien Van Olmen, Htun Nyunt Oo, Lutgarde Lynen
Viraemic-time predicts mortality among people living with HIV on second-line antiretroviral treatment in Myanmar: A retrospective cohort study. PloS one 17 (7) (2022)
Armand Van Deun, Tom Decroo, Kya Jai Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Willem Bram De Rijk, Sabira Tahseen, Bouke Catherine de Jong, Leen Rigouts
Mycobacterium tuberculosis borderline rpoB mutations: emerging from the unknown. The European respiratory journal 58 (3) (2021)
Ivan Alejandro Pulido Tarquino, Emilie Venables, Rajá Reis Simone, Jose M de Amaral Fidelis, Tom Decroo
"I don't know when he will be back": life-changing events challenge the community ART Group model- a qualitative research study, Tete, Mozambique. BMC public health 21 (1) (2021)
Armand Van Deun, Tom Decroo
How Second-Line Injectable Drugs Work. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 72 (12) (2021)
Souleymane Mahamadou Bassirou, Alberto Piubello, Ibrahim Mamane Lawan, Souleymane Hassane-Harouna, Mourtala Mohamed Assao-Neino, Alphazazi Soumana, Zelika Hamidou-Harouna, Assiatou Gagara-Issoufou, Nimer Ortuño-Gutiérrez, Alberto Roggi, Valerie Schwoebel, Saïdou Mamadou, Lutgarde Lynen, Bouke Catherine de Jong, Armand Van Deun, Tom Decroo
High rifampicin-resistant TB cure rates and prevention of severe ototoxicity after replacing the injectable by linezolid in early stage of hearing loss. The European respiratory journal 57 (1) (2021)
Tom Decroo, Kya Jai, Maug Aung, Mohamed Anwar Hossain, Mourad Gumusboga, Nimer Ortuno-Gutierrez, Bouke Catherine, Bouke Catherine de Jong, Armand Van Deun
Bedaquiline can act as core drug in a standardized treatment regimen for fluoroquinolone-resistant rifampicin-resistant tuberculosis. The European respiratory journal (2021)
Tom Decroo, Bouke C de Jong, Alberto Piubello, Mahamadou Bassirou Souleymane, Lutgarde Lynen, Armand Van Deun
High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis. American journal of respiratory and critical care medicine 201 (12) (2020)
Richard Makurumidze, Tsitsi Mutasa-Apollo, Tom Decroo, Regis C Choto, Kudakwashe C Takarinda, Janet Dzangare, Lutgarde Lynen, Wim Van Damme, James Hakim, Tapuwa Magure, Owen Mugurungi, Simbarashe Rusakaniko
Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015. PloS one 15 (1) (2020)
Armand Van Deun, Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Mourad Gumusboga, Wim Mulders, Nimer Ortuño-Gutiérrez, Lutgarde Lynen, Bouke C de Jong, Hans L Rieder
The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance. PloS one 15 (5) (2020)
Tom Decroo, Aung Kya Jai Maug, Mohamed Anwar Hossain, Cécile Uwizeye, Mourad Gumusboga, Tine Demeulenaere, Nimer Ortuño-Gutiérrez, Bouke C de Jong, Armand Van Deun
Injectables' key role in rifampicin-resistant tuberculosis shorter treatment regimen outcomes. PloS one 15 (8) (2020)
Kimcheng Choun, Tom Decroo, Tan Eang Mao, Natalie Lorent, Lisanne Gerstel, Jacob Creswell, Andrew J Codlin, Lutgarde Lynen, Sopheak Thai
Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study. Global health action 12 (1) (2020)
François Ciza, Tinne Gils, Michel Sawadogo, Tom Decroo, Alberto Roggi, Alberto Piubello, Nimer Ortuño-Gutiérrez
Course of Adverse Events during Short Treatment Regimen in Patients with Rifampicin-Resistant Tuberculosis in Burundi. Journal of clinical medicine 9 (6) (2020)
Tom Decroo, Alexandre Delamou, John C Reeder
Operational research: did health systems in Sierra Leone recover after the 2014-15 Ebola outbreak? F1000Research 8 (2019)
Arnaud Trébucq, Tom Decroo, Armand Van Deun, Alberto Piubello, Chen-Yuan Chiang, Kobto G Koura, Valérie Schwoebel
Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence. Journal of clinical medicine 9 (1) (2019)
Tom Decroo, Rafael Van den Bergh, Ajay M V Kumar, Rony Zachariah, Erin Schillberg, Philip Owiti, Wilma van den Boogaard, Guido Benedetti, Safieh Shah, Engy Ali, Anthony D Harries, Anthony J Reid
Blended SORT-IT for operational research capacity building: the model, its successes and challenges. Global health action 11 (1) (2018)
Tom Decroo, Aquiles R Henríquez-Trujillo, Anja De Weggheleire, Lutgarde Lynen
Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold. BMC infectious diseases 17 (1) (2017)

Tom Decroo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tom Decroo